| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0005 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0005 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0006 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.18 | 0.0006 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.21 | 0.0007 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0007 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0008 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0008 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.001 |